학술논문
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
Document Type
Article
Author
Mayer, K.H.; Molina, J.-M.; Thompson, M.A.; Anderson, P.L.; Mounzer, K.C.; De Wet, J.J.; DeJesus, E.; Jessen, H.; Grant, R.M.; Ruane, P.J.; Wong, P.; Ebrahimi, R.; Zhong, L.; Mathias, A.; Callebaut, C.; Collins, S.E.; Das, M.; McCallister, S.; Brainard, D.M.; Brinson, C.; Clarke, A.; Coll, P.; Post, F.A.; Hare, C.B.
Source
In: The Lancet . (The Lancet, 25 - 31 July 2020, 396(10246):239-254)
Subject
Language
English
ISSN
1474547X
01406736
01406736